Abeona Therapeutics (ABEO) Interest Coverage Ratio Growth (5y) (2016 - 2026)
Abeona Therapeutics (ABEO) Interest Coverage Ratio Growth (5y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
Abeona Therapeutics |
309.15 Mn |
140.88 Mn |
6.02 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-21.97% |
| Dec 31, 2025 |
61.06% |
| Sep 30, 2025 |
-41.45% |
| Jun 30, 2025 |
-8.83% |
| Mar 31, 2025 |
24.46% |
| Dec 31, 2023 |
57.75% |
| Sep 30, 2023 |
54.67% |
| Jun 30, 2023 |
52.38% |
| Mar 31, 2023 |
49.31% |
| Dec 31, 2022 |
61.64% |
| Sep 30, 2022 |
53.27% |
| Jun 30, 2022 |
57.28% |
| Mar 31, 2022 |
47.80% |
| Dec 31, 2021 |
21.30% |
| Sep 30, 2021 |
66.52% |
| Jun 30, 2021 |
73.28% |
| Mar 31, 2021 |
68.03% |
| Dec 31, 2020 |
68.04% |
| Sep 30, 2020 |
76.20% |
| Jun 30, 2020 |
62.35% |
